XXQ

(8-oxo-7-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-7,8-dihydropyrazino[2,3-d]pyridazin-5-yl)acetic acid


Toggle HydrogenToggle Labels

Chemical Component Summary

Name(8-oxo-7-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-7,8-dihydropyrazino[2,3-d]pyridazin-5-yl)acetic acid
Identifiers2-[5-oxidanylidene-6-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]pyrazino[2,3-d]pyridazin-8-yl]ethanoic acid
FormulaC17 H10 F3 N5 O3 S
Molecular Weight421.353
TypeNON-POLYMER
Isomeric SMILESc1cc2c(cc1C(F)(F)F)nc(s2)CN3C(=O)c4c(nccn4)C(=N3)CC(=O)O
InChIInChI=1S/C17H10F3N5O3S/c18-17(19,20)8-1-2-11-9(5-8)23-12(29-11)7-25-16(28)15-14(21-3-4-22-15)10(24-25)6-13(26)27/h1-5H,6-7H2,(H,26,27)
InChIKeyYRGPAXAVTDMKDK-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count39
Chiral Atom Count0
Bond Count42
Aromatic Bond Count16

Drug Info: DrugBank

DrugBank IDDB15121 
NameAT-001
Groups investigational
DescriptionAT-001 is under investigation in clinical trial NCT03062384 (AT-001 for Long-term Preservation of Brain Health in Aging).
SynonymsAT-001
Categories
  • Heterocyclic Compounds, Fused-Ring
  • Pyridines
  • Thiazoles
CAS number1355612-71-3

Related Resource References

Resource NameReference
PubChem 56639723
ChEMBL CHEMBL4297455